Related references
Note: Only part of the references are listed.Stimulated GH levels during the transition phase in Prader-Willi syndrome
G. Grugni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Long-Acting Growth Hormone Preparations - Current Status and Future Considerations
Bradley S. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
Layla Damen et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial
Stephany H. Donze et al.
CLINICAL ENDOCRINOLOGY (2018)
Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome
Mikiko Koizumi et al.
ENDOCRINE JOURNAL (2018)
Beneficial Effects of GH in Young Adults With Prader-Willi Syndrome: A 2-Year Crossover Trial
Renske J. Kuppens et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Maria Fleseriu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial
R. J. Kuppens et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Growth hormone therapy for Prader-Willi syndrome: challenges and solutions
Graziano Grugni et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)
Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition
Charlotte Hoybye
ACTA PAEDIATRICA (2015)
Skeletal Muscle Characteristics and Motor Performance After 2-Year Growth Hormone Treatment in Adults With Prader-Willi Syndrome
Claudio L. Lafortuna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Two Years of Growth Hormone Treatment in Adults With Prader-Willi Syndrome Do Not Improve the Low BMD
A. P. Jorgensen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
Cheri L. Deal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis
Ruth Sanchez-Ortiga et al.
CLINICAL ENDOCRINOLOGY (2012)
Nutritional Phases in Prader-Willi Syndrome
Jennifer L. Miller et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Rasmus Sode-Carlsen et al.
GROWTH HORMONE & IGF RESEARCH (2011)
Recommendations for the Diagnosis and Management of Prader-Willi Syndrome
A. P. Goldstone et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome
L. A. Gondoni et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome
Charlotte Hoybye
ACTA PAEDIATRICA (2007)
Quality of life and psychological well-being in GH-treated, adult PWS patients: a longitudinal study
L. Bertella et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2007)
Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome
C Höybye et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2005)
Share Paper
